Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
Your numbers guide the protocol, not assumptions
10.1016/j.fertnstert.2007.02.067 71
Support for clinical significance came from a responder analysis based on an anchored assessment, which evaluated participants perception of benefit
Inflammopharmacology 14:214221 Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S (2009) Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing
Many patients lack balanced, clinically accurate information